Vaccines prevent not only diseases, but also poverty:
New study in Health Affairs states that in addition to saving 36 million lives, vaccines administered between 2016 and 2030 will help prevent 24 million people from slipping into poverty.
“A healthy child is more likely to go to school and become a more productive member of society in later life” - Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance. “To realise these figures we now need to redouble our efforts to ensure every child, no matter where they’re born, has access to lifesaving vaccines.”https://lnkd.in/g3avnpY
Univercells is proud to announce the appointment of David Shofi as its new Chief Legal Officer. We are excited to partner with him as our first US-based collaborator in our work to make biologics for all. We will employ his keen expertise from 20+ years in IP and general corporate law in our next chapter, strengthening our IP strategy and protecting our innovative developments as we move onward and upward with our mission!
Read full article here: https://goo.gl/5u6gVA
We are looking forward to WCBP’s 22nd Symposium on the Interface of Regulatory & Analytical Sciences for Biotechnology Health Products! Benjamin Damien will discuss affordable vaccine manufacturing through disruptive micro-facility technology. https://goo.gl/vsh7pa
Univercells to receive €2.4M from Walloon Region for its “Universimilar” program
New endowment to open avenues for the development of Univercells’ innovative antibody manufacturing platform – its ultimate goal being to usher in significant industry advances for cheaper production and broader deployment of biologics worldwide. Future applications of the program include oncology, auto-immune and rare diseases.Read full press release: https://lnkd.in/g3hcbQb
Upset by Big Pharma practices, some large American hospitals launch locally based non-profit generic drug companies - increasing competition equals industrial paradigm shifts, economic benefits for patients, and reduced impact from any shortages. Is this an omen of things to come?https://lnkd.in/g9S53s3
Univercells secures €3M Series A2 funding.
This capital injection will help accelerate the development and commercialization of the company’s technology platforms and innovative solutions. Read the full Press Release: https://lnkd.in/dfJ_anD
Univercells in Pharmaceutical Technology
Read about 'Accelerating Vaccines Development and Manufacturing' with insights from UNIVERCELLS Chief Technology Officer, Jose Castillo, one of the reference innovators in the field: https://goo.gl/dq39Es